Bioventus Inc (BVS) earnings · P/E 17, rev $568.1M
These earnings events as JSON? API free 100/dayBioventus Inc (BVS) is a medical devices company listed on US.
This BVS earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported BVS revenue for 2025-12-31 was $568.1M. Net income was $22.7M. Revenue was down 0.9% from 2024-12-31 to 2025-12-31. BVS currently screens at market cap $495.1M and trailing P/E 17.1.
When the next BVS 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 0.9% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full BVS research stays on the stock page; the tape stays on the quote page.
BVS earnings FAQ
What are BVS's latest revenue and net income?
Latest cached Bioventus Inc (BVS) revenue for Dec 31, 2025 was $568.1M. Net income was $22.7M. Statements: https://lician.com/financials/bvs
What is BVS's latest diluted EPS?
Latest cached Bioventus Inc (BVS) diluted EPS for Dec 31, 2025 was $0.33.
What period does the latest BVS earnings print cover?
The latest cached Bioventus Inc (BVS) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did BVS revenue change from the prior cached period?
Cached Bioventus Inc (BVS) revenue was down 0.9% from $573.3M (Dec 31, 2024) to $568.1M (Dec 31, 2025). Statements: https://lician.com/financials/bvs
What is BVS's P/E ratio?
Bioventus Inc (BVS) trailing P/E is 17.1 on the latest cached fundamentals snapshot.
Where are BVS earnings listed?
Cached earnings facts for Bioventus Inc (BVS) are listed at https://lician.com/earnings/bvs. Statements: https://lician.com/financials/bvs
Not investment advice.